NeuroBo Pharmaceuticals, Inc. - stock earnings

NRBO Quarterly earnings

DateEarningsRevenue
2023Q3 -3.8 million USD ? USD
2023Q2 -734000 USD ? USD
2023Q1 -2.7 million USD ? USD
2022Q4 994000 USD ? USD
2022Q3 -3.1 million USD ? USD
2022Q2 -3.4 million USD ? USD
2022Q1 -2.9 million USD ? USD
2021Q4 -4.6 million USD ? USD
2021Q3 -3.5 million USD ? USD
2021Q2 -3.9 million USD ? USD
2021Q1 -19.5 million USD ? USD
2020Q4 -29.7 million USD ? USD
2020Q3 -3.1 million USD ? USD
2020Q2 -2.4 million USD ? USD
2020Q1 -4.7 million USD ? USD
2019Q4 -11.2 million USD ? USD
2019Q3 -3.4 million USD ? USD
2019Q2 -2.9 million USD ? USD
2019Q1 -3.8 million USD ? USD
2018Q4 -3.7 million USD ? USD
2018Q3 -6.1 million USD ? USD
2018Q2 -6.7 million USD ? USD
2018Q1 -7.2 million USD ? USD
2017Q4 -6.7 million USD ? USD
2017Q3 -8.7 million USD ? USD
2017Q2 -10.5 million USD ? USD
2017Q1 -7.5 million USD ? USD
2016Q4 -7.2 million USD ? USD
2016Q3 -3.9 million USD ? USD
2016Q2 -1.4 million USD ? USD
2016Q1 -2.1 million USD ? USD
2015Q4 -2.6 million USD ? USD
2015Q3 -2.6 million USD ? USD
2015Q2 -1.6 million USD ? USD
2015Q1 -2.3 million USD ? USD

NRBO Yearly earnings

DateEarningsRevenue
2023 -11.8 million USD ? USD
2022 -6.1 million USD ? USD
2021 -15.2 million USD ? USD
2020 -29.6 million USD ? USD
2019 -22.4 million USD ? USD
2018 -23.6 million USD ? USD
2017 -33.4 million USD ? USD
2016 -14.6 million USD ? USD
2015 -9.0 million USD ? USD
2014 -320000 USD ? USD

NRBO

Price: $3.98

52 week price:
2.89
6.75

Earnings Per Share: -2.46 USD

P/E Ratio: -0.12

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 985600

Market Capitalization: 18.5 million

Links: